[1]
|
Keni, R., Sekhar, A., Gourishetti, K., Nayak, P.G., Kinra, M., Kumar, N., et al. (2021) Role of Statins in New-Onset Diabetes Mellitus: The Underlying Cause, Mechanisms Involved, and Strategies to Combat. Current Drug Targets, 22, 1121-1128. https://doi.org/10.2174/1389450122666210120125945
|
[2]
|
Seo, W.W., Seo, S.I., Kim, Y., Yoo, J.J., Shin, W.G., Kim, J., et al. (2022) Impact of Pitavastatin on New-Onset Diabetes Mellitus Compared to Atorvastatin and Rosuvastatin: A Distributed Network Analysis of 10 Real-World Databases. Cardiovascular Diabetology, 21, Article No. 82. https://doi.org/10.1186/s12933-022-01524-6
|
[3]
|
Cai, T., Abel, L., Langford, O., Monaghan, G., Aronson, J.K., Stevens, R.J., et al. (2021) Associations between Statins and Adverse Events in Primary Prevention of Cardiovas-cular Disease: Systematic Review with Pairwise, Network, and Dose-Response Meta-Analyses. BMJ, 374, n1537. https://doi.org/10.1136/bmj.n1537
|
[4]
|
Strandberg, T.E. (2019) Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients. Current Atherosclerosis Reports, 21, Article No. 28. https://doi.org/10.1007/s11883-019-0793-7
|
[5]
|
Zhou, Q. and Liao, J.K. (2010) Pleiotropic Effects of Statins. Basic Research and Clinical Perspectives. Circulation Journal, 74, 818-826. https://doi.org/10.1253/circj.CJ-10-0110
|
[6]
|
Chamani, S., Kooshkaki, O., Moossavi, M., Rastegar, M., Soflaei, S.S., McCloskey, A.P., Banach, M. and Sahebkar, A. (2022) The Effects of Statins on the Function and Differentiation of Blood Cells. Archives of Medical Science, 19, 1314-1326. https://doi.org/10.5114/aoms/158546
|
[7]
|
Yang, G. and Schooling, C.M. (2023) Statins, Type 2 Diabetes, and Body Mass Index: A Univariable and Multivariable Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism, 108, 385-396.
https://doi.org/10.1210/clinem/dgac562
|
[8]
|
Mansi, I.A., Chansard, M., Lingvay, I., Zhang, S., Halm, E.A. and Alvarez, C.A. (2021) Association of Statin Therapy Initiation with Diabetes Progression: A Retrospective Matched-Cohort Study. JAMA Internal Medicine, 181, 1562-1574.
https://doi.org/10.1001/jamainternmed.2021.5714
|
[9]
|
Chogtu, B., Magazine, R. and Bairy, K.L. (2015) Statin Use and Risk of Diabetes Mellitus. World Journal of Diabetes, 6, 352-357. https://doi.org/10.4239/wjd.v6.i2.352
|
[10]
|
Freeman, D.J., Norrie, J., Sattar, N., Neely, R.D., Cobbe, S.M., Ford, I., et al. (2001) Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study. Circulation, 103, 357-362. https://doi.org/10.1161/01.CIR.103.3.357
|
[11]
|
Ridker, P.M., Pradhan, A., MacFadyen, J.G., Libby, P. and Glynn, R.J. (2012) Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention: An Analysis from the JUPITER Trial. The Lancet, 380, 565-571.
https://doi.org/10.1016/S0140-6736(12)61190-8
|
[12]
|
Yoon, D., Sheen, S.S., Lee, S., Choi, Y.J., Park, R.W. and Lim, H.S. (2016) Statins and Risk for New-Onset Diabetes Mellitus: A Real-World Cohort Study Using a Clinical Re-search Database. Medicine (Baltimore), 95, e5429.
https://doi.org/10.1097/MD.0000000000005429
|
[13]
|
Ooba, N., Setoguchi, S., Sato, T. and Kubota, K. (2017) Li-pid-Lowering Drugs and Risk of New-Onset Diabetes: A Cohort Study Using Japanese Healthcare Data Linked to Clin-ical Data for Health Screening. BMJ Open, 7, e015935.
https://doi.org/10.1136/bmjopen-2017-015935
|
[14]
|
Li, H., Lin, H., Zhao, H., Xu, Y., Cheng, Y., Shen, P. and Zhan, S. (2018) Statins Use and Risk of New-Onset Diabetes in Hypertensive Patients: A Population-Based Retrospec-tive Cohort Study in Yinzhou District, Ningbo City, People’s Republic of China. Therapeutics and Clinical Risk Man-agement, 14, 823-832. https://doi.org/10.2147/TCRM.S158850
|
[15]
|
Abbasi, F., Lamendola, C., Harris, C.S., Har-ris, V., Tsai, M.S., Tripathi, P., et al. (2021) Statins Are Associated with Increased Insulin Resistance and Secretion. Ar-teriosclerosis, Thrombosis, and Vascular Biology, 41, 2786-2797.
https://doi.org/10.1161/ATVBAHA.121.316159
|
[16]
|
Cederberg, H., Stančáková, A., Yaluri, N., Modi, S., Kuu-sisto, J. and Laakso, M. (2015) Increased Risk of Diabetes with Statin Treatment Is Associated with Impaired Insulin Sensitivity and Insulin Secretion: A 6 Year Follow-Up Study of the METSIM Cohort. Diabetologia, 58, 1109-1117. https://doi.org/10.1007/s00125-015-3528-5
|
[17]
|
Sattar, N., Preiss, D., Murray, H.M., Welsh, P., Buckley, B.M., de Craen, A.J.M., et al. (2010) Statins and Risk of Incident Diabetes: A Collaborative Meta-Analysis of Randomised Statin Trials. The Lancet, 375, 735-742.
https://doi.org/10.1016/S0140-6736(09)61965-6
|
[18]
|
Preiss, D., Seshasai, S.R., Welsh, P., Murphy, S.A., Ho, J.E., Waters, D.D., et al. (2011) Risk of Incident Diabetes with Intensive-Dose Compared with Moderate-Dose Statin Therapy: A Meta-Analysis. JAMA, 305, 2556-2564.
https://doi.org/10.1001/jama.2011.860
|
[19]
|
Thakker, D., Nair, S., Pagada, A., Zamdade, V. and Malik, A. (2016) Statin Use and the Risk of Developing Diabetes: A Network Meta-Analysis. Pharmacoepidemiology and Drug Safety, 25, 1131-1149. https://doi.org/10.1002/pds.4020
|
[20]
|
Erqou, S., Lee, C.C. and Adler, A.I. (2014) Statins and Gly-caemic Control in Individuals with Diabetes: A Systematic Review and Meta-Analysis. Diabetologia, 57, 2444-2452. https://doi.org/10.1007/s00125-014-3374-x
|
[21]
|
Alvarez-Jimenez, L., Morales-Palomo, F., Moreno-Cabañas, A., Ortega, J.F. and Mora-Rodrıguez, R. (2023) Effects of Statin Therapy on Glycemic Control and Insulin Resistance: A Systematic Review and Meta-Analysis. European Journal of Pharmacology, 947, Article ID: 175672. https://doi.org/10.1016/j.ejphar.2023.175672
|
[22]
|
Cui, J.Y., Zhou, R.R., Han, S., Wang, T.S., Wang, L.Q. and Xie, X.H. (2018) Statin Therapy on Glycemic Control in Type 2 Diabetic Patients: A Network Meta-Analysis. Journal of Clinical Pharmacy and Therapeutics, 43, 556-570.
https://doi.org/10.1111/jcpt.12690
|
[23]
|
Swerdlow, D.I., Preiss, D., Kuchenbaeker, K.B., et al. (2015) HMG-Coenzyme Reductase Inhibition, Type 2 Diabetes, and Bodyweight: Evidence from Genetic Analysis and Ran-domised Trials. The Lancet, 385, 351-361.
https://doi.org/10.1016/S0140-6736(14)61183-1
|
[24]
|
Guber, K., Pemmasani, G., Malik, A., Aronow, W.S., Yandrapalli, S. and Frishman, W.H. (2021) Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications. Cardiology in Review, 29, 314-322. https://doi.org/10.1097/CRD.0000000000000348
|
[25]
|
Perego, C., Da Dalt, L., Pirillo, A., Galli, A., Catapano, A.L. and Norata, G.D. (2019) Cholesterol Metabolism, Pancreaticb-Cell Function and Diabetes. BBA Molecular Basis of Dis-ease, 1865, 2149-2156.
https://doi.org/10.1016/j.bbadis.2019.04.012
|
[26]
|
Takei, S., Nagashima, S., Takei, A., Yamamuro, D., Waka-bayashi, T., Murakami, A., et al. (2020) b-Cell-Specific Deletion of HMG-CoA (3-Hydroxy-3-methylglutaryl-coenzyme A) Reductase Causes Overt Diabetes Due to Reduction of b-Cell Mass and Impaired Insulin Secretion. Diabetes, 69, 2352-2363. https://doi.org/10.2337/db19-0996
|
[27]
|
Mbikay, M., Sirois, F., Mayne, J., Wang, G.-S., Chen, A., Dewpura, T., et al. (2010) PCSK9-Deficient Mice Exhibit Impaired Glucose Tolerance and Pancreatic Islet Abnormalities. FEBS Letters, 584, 701-706.
https://doi.org/10.1016/j.febslet.2009.12.018
|
[28]
|
Yaluri, N., Modi, S., Lopez Rodrıguez, M., Stancakova, A., Kuusisto, J., Kokkola, T., et al. (2015) Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells. PLOS ONE, 10, e0142902.
https://doi.org/10.1371/journal.pone.0142902
|
[29]
|
Zhou, J., Li, W., Xie, Q., Hou, Y., Zhan, S., Yang, X., et al. (2014) Effects of Simvastatin on Glucose Metabolism in Mouse MIN6 Cells. Journal of Diabetes Research, 2014, Arti-cle ID: 376570. https://doi.org/10.1155/2014/376570
|
[30]
|
Yandrapalli, S., Malik, A., Guber, K., Rochlani, Y., Pemmasani, G., Jasti, M. and Aronow, W.S. (2019) Statins and the Potential for Higher Diabetes Mellitus Risk. Expert Review of Clinical Pharmacology, 12, 825-830.
https://doi.org/10.1080/17512433.2019.1659133
|
[31]
|
Paseban, M., Butler, A.E. and Sahebkar, A. (2019) Mecha-nisms of Statin-Induced New-Onset Diabetes. Journal of Cellular Physiology, 234, 12551-12561. https://doi.org/10.1002/jcp.28123
|
[32]
|
Yada, T., Nakata, M., Shiraishi, T. and Kakei, M. (1999) Inhibition by Simvastatin, but Not Pravastatin, of Glucose-Induced Cytosolic Ca2+ Signalling and Insulin Secretion Due to Blockade of L-Type Ca2+ Channels in Rat Islet Beta-Cells. British Journal of Pharmacology, 126, 1205-1213. https://doi.org/10.1038/sj.bjp.0702397
|
[33]
|
Donath, M.Y., Böni-Schnetzler, M., Ellingsgaard, H., et al. (2009) Islet Inflammation Impairs the Pancreatic Beta-Cell in Type 2 Diabetes. Physiology (Bethesda), 24, 325-331. https://doi.org/10.1152/physiol.00032.2009
|
[34]
|
Besseling, J., Kastelein, J.J., Defesche, J.C., et al. (2015) Associ-ation between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus. JAMA, 313, 1029-1036. https://doi.org/10.1001/jama.2015.1206
|
[35]
|
Da Dalt, L., Ruscica, M., Bonacina, F., Balzarotti, G., Dhyani, A., Di Cairano, E., et al. (2019) PCSK9 Deficiency Reduces Insulin Secretion and Promotes Glucose Intolerance: The Role of the Low-Density Lipoprotein Receptor. European Heart Journal, 40, 357-368. https://doi.org/10.1093/eurheartj/ehy357
|
[36]
|
Sattar, N. (2023) Statins and Diabetes: What Are the Connections? Best Practice & Research Clinical Endocrinology & Metabolism, 37, Article ID: 101749. https://doi.org/10.1016/j.beem.2023.101749
|
[37]
|
Grunwald, S.A., Haafke, S., Grieben, U., Kassne, U., Steinha-gen-Thiessen, E. and Spuler, S. (2022) Statins Aggravate the Risk of Insulin Resistance in Human Muscle. International Journal of Molecular Sciences, 23, Article No. 2398.
https://doi.org/10.3390/ijms23042398
|
[38]
|
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C.N., Bang, L.E., Bundgaard, H., et al. (2013) Simvastatin Effects on Skeletal Muscle: Relation to Decreased Mitochondrial Function and Glucose Intolerance. Journal of the American College of Cardiology, 61, 44-53. https://doi.org/10.1016/j.jacc.2012.09.036
|
[39]
|
Ahrén, B. (2015) Glucagon-Early Breakthroughs and Recent Dis-coveries. Peptides, 67, 74-81.
https://doi.org/10.1016/j.peptides.2015.03.011
|
[40]
|
Urbano, F., Di Pino, A., Scicali, R., et al. (2019) Impaired Glucagon Suppression and Reduced Insulin Sensitivity in Subjects with Prediabetes Undergoing Atorvastatin Therapy. European Journal of Endocrinology, 181, 579-590.
https://doi.org/10.1530/EJE-19-0173
|